However, no EPHA2 mutations were detected in the TCGA-GCA IIB to IV samples, and in the TCGA-GCA samples staged as I–IIA, 2 patients (2/37) had EPHA2 mutations, which were not in the kinase domain (Fig. 2D). This evidence concerns the gene EPHA2 and temporal arteritis.